| 1 |
28479356 | Quantitative Analysis of Complex Drug-Drug Interactions Between Repaglinide and Cyclosporin A/Gemfibrozil Using Physiologically Based Pharmacokinetic Models With In Vitro Transporter/Enzyme Inhibition Data. | 2017 Sep |
1 |
| 2 |
20208386 | System-dependent outcomes during the evaluation of drug candidates as inhibitors of cytochrome P450 (CYP) and uridine diphosphate glucuronosyltransferase (UGT) enzymes: human hepatocytes versus liver microsomes versus recombinant enzymes. | 2010 |
1 |
| 3 |
15771232 | Comparative effects of fibrates on drug metabolizing enzymes in human hepatocytes. | 2005 Jan |
1 |
| 4 |
16042675 | Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide. | 2005 Aug |
2 |
| 5 |
16283275 | Effect of gemfibrozil on the pharmacokinetics of pioglitazone. | 2005 Dec |
1 |
| 6 |
15194707 | Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil. | 2004 Oct |
1 |
| 7 |
14682608 | Interaction between fibrates and statins--metabolic interactions with gemfibrozil. | 2003 |
1 |
| 8 |
12023536 | Mechanistic studies on metabolic interactions between gemfibrozil and statins. | 2002 Jun |
3 |
| 9 |
12386136 | Effects of fibrates on metabolism of statins in human hepatocytes. | 2002 Nov |
3 |
| 10 |
12433802 | Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomes. | 2002 Dec |
1 |